ANDA 76473, held by Hospira. Carboplatin.
As of Nov 15, 2026, ANDA 76473 (Carboplatin), held by Hospira, was first approved by FDA on Oct 27, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 27, 2004 | Original application | Approved | None posted |
| Carboplatin50MG/VIAL · injectable;injection | Carboplatin | Discontinued |
| Carboplatin150MG/VIAL · injectable;injection | Carboplatin | Discontinued |
| Carboplatin450MG/VIAL · injectable;injection | Carboplatin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
